StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Volume

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jun 06, 2023 2:29pm

76 Views

Post# 35482914

RE:Volume

We finally made it down to a NICKLE, yup thats five cents, took a lot of work on Tripp's part but he did it. Wow.

telman wrote: Boy a guy sure can tell how excited people are about the program tomorrow. That volume is off the charts.

wow

At this point I only think about how bad it will be rather than anything good coming from Tripp and this current management team.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec